Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: August 13, 2022

Details for Patent: 7,049,328

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 7,049,328
Title:Use for deferiprone
Abstract: A method of treating iron induced cardiac disease in a patient with iron overload, such as in thalassemia or the like comprising administering to the patient a therapeutically effective amount of deferiprone or a physiologically acceptable salt thereof sufficient to treat iron induced cardiac disease normally associated with iron overload.
Inventor(s): Spino; Michael (Pickering, CA), Piga; Antonio (Moncalieri, IT)
Assignee: Apotex Inc. (Weston, CA)
Application Number:10/311,814
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,049,328
Patent Claim Types:
see list of patent claims
Use; Delivery; Composition; Dosage form; Formulation;

Drugs Protected by US Patent 7,049,328

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,049,328

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Canada2313270Jun 30, 2000
PCT Information
PCT FiledJune 28, 2001PCT Application Number:PCT/CA01/00956
PCT Publication Date:January 10, 2002PCT Publication Number: WO02/02114

International Family Members for US Patent 7,049,328

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 427107 See Plans and Pricing
Australia 2001270402 See Plans and Pricing
Australia 7040201 See Plans and Pricing
Brazil 0112280 See Plans and Pricing
Canada 2313270 See Plans and Pricing
China 101380322 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.